James H. Fleming

898 citations
25 papers · 590 · 1 hit paper · h-index 10

Impact in

Papers in

James H. Fleming

22 papers receiving 569 citations

Hit Papers

Empagliflozin in Heart Failure 2020 · 270 citations
2700+2+4Years since publication50100150200250

Peers

James H. Fleming
Comparison fields: 5 of 79
  • Nephrology 132
  • Endocrinology, Diabetes and Metabolism 227
  • Cardiology and Cardiovascular Medicine 229
  • Pulmonary and Respiratory Medicine 171
  • Ecological Modeling 18
Replace José Antonio Gimeno-Orna with:
José Antonio Gimeno-Orna Spain
Samuel Spitalewitz United States
Wing-Bun Chan Hong Kong
Andrea Pota Italy
Judita Knez Belgium
A. Sofia Italy
Eugene Clark United States
Konstantinos Leivaditis Greece
Abdullah Tekin Türkiye
Chunyu Ruan China
James H. Fleming relative to José Antonio Gimeno-Orna Spain José Antonio Gimeno-Orna's profile →
Citations per field
00.5×10×15×18×
José Antonio Gimeno-Orna · 1×
Citations per year

Countries citing papers authored by James H. Fleming

Since Specialization
Citations

This map shows the geographic impact of James H. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Fleming more than expected).

Fields of papers citing papers by James H. Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Fleming. The network helps show where James H. Fleming may publish in the future.

Co-authors

The 25 scholars most cited alongside James H. Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James H. Fleming Line = papers co-authored together James H. Fleming links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Empagliflozin in Heart Failure
Hit paper breakdown →
2020270
2 2005116
3 202141
4 201233
5 202027
6 201917
7 202017
8 202011
9 196311
10 198810
11 20209
12 19776
13 20064
14 20194
15 20233
16 20202
17 20202
18 20202
19 20192
20 20191

About James H. Fleming

James H. Fleming is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pulmonary and Respiratory Medicine, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 25 papers that have together received 590 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (9 papers), Hemodynamic Monitoring and Therapy (5 papers), Electrolyte and hormonal disorders (4 papers), Diabetes Treatment and Management (3 papers), Dialysis and Renal Disease Management (2 papers), Blood Pressure and Hypertension Studies (2 papers), Potassium and Related Disorders (2 papers) and Nutrition and Health in Aging (2 papers). The work is most often cited by research in Nephrology (132 citations), Endocrinology, Diabetes and Metabolism (227 citations), Cardiology and Cardiovascular Medicine (229 citations), Pulmonary and Respiratory Medicine (171 citations) and Ecological Modeling (18 citations). James H. Fleming has collaborated with scholars based in United States, Mexico and Brazil. Frequent co-authors include Juan B. Ivey‐Miranda, Veena S. Rao, Matthew D. Griffin, Jeffrey M. Testani, Devin Mahoney, Zachary L. Cox, F. Perry Wilson, Christopher Maulion, Ralph J. Riello and Jeffrey M. Turner. Their work appears in journals such as Journal of Cardiac Failure, ESC Heart Failure, Journal of the American College of Cardiology, Biodiversity and Conservation and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact